Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIFE-Study
DRKS00004394Phase 3Completed
- Sponsor
- Pierre Fabre Médicament Represented by: Institut de Recherche Pierre Fabre Anne Maret 45, Place Abel Gance
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial in ischemic stroke and brain infarction comparing Levomilnacipran 75 mg OD with Placebo (2 arms). Started May 2013; status: completed.
02
Drugs
levomilnacipran
03
Conditions
ischemic strokebrain infarction
Beyond the preview
Go deeper on DRKS00004394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004394.